Results 121 to 130 of about 45,865 (256)

Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study

open access: yesClinical and Translational Medicine, Volume 16, Issue 9, September 2026.
This study prospectively evaluated the efficacy and safety of the bevacizumab, nab‐paclitaxel and platinum combination as a second‐line therapy for driver‐gene‐negative advanced non‐squamous non‐small cell lung cancer after immunochemotherapy. The confirmed objective response rate was 46.4%.
Ying Lin   +12 more
wiley   +1 more source

Hypercalcemia: a consultant\u27s approach.

open access: yes, 2018
Due to their daily involvement in mineral metabolism, nephrologists are often asked to consult on children with hypercalcemia. This might become even more pertinent when the hypercalcemia is associated with acute kidney injury and/or hypercalciuria and ...
Auron, Ari, Alon, Uri S
core   +1 more source

A Clinically Aligned Two‐Stage Machine Learning Framework for Predicting Hungry Bone Syndrome After Parathyroidectomy

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
A clinically aligned two‐stage machine learning framework integrates preoperative and perioperative features to predict hungry bone syndrome after parathyroidectomy. Explainable risk stratification may support individualised calcium management and early intervention for high‐risk patients.
Shih‐Min Yin   +10 more
wiley   +1 more source

Hypercalcemia: A Practice Overview of Its Diagnosis and Causes

open access: yesKidney and Dialysis
Hypercalcemia is defined as a serum calcium concentration higher than 10.5 mg/gL or 2.6 mmol/L. Only 50% of serum calcium is active, presented as ionized calcium.
Vincenzo Calabrese   +9 more
doaj   +1 more source

Acute and Chronic Pancreatitis in Mitochondrial Disease: A Systematic Review

open access: yesJIMD Reports, Volume 67, Issue 5, September 2026.
ABSTRACT Mitochondrial disease is a common inherited multisystem neurometabolic disorder. Pancreatic dysfunction is a recognised manifestation, most frequently presenting as mitochondrial diabetes. Although pancreatitis cases have been reported in association with mitochondrial disease, acute and chronic pancreatitis in this context remain poorly ...
Olivia Hahl, Mika H. Martikainen
wiley   +1 more source

Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report

open access: yesCase Reports in Oncological Medicine
Hypercalcemia of malignancy is a well-known phenomenon in cancer patients, often associated with poor prognosis. The discovery of immune checkpoint inhibitors has revolutionised cancer therapy by improving prognosis in numerous different cancer types ...
Sam Plessers   +5 more
doaj   +1 more source

Hypercalcemia of malignancy treated with cinacalcet

open access: yes, 2017
Summary Hypercalcemia of malignancy is the most common cause of hypercalcemia in hospitalized patients. It is associated with a poor prognosis, since it reflects an advanced cancer stage.
Michalis Kokkinos   +5 more
core   +1 more source

Disseminated tuberculosis presented with explicit hypercalcemia: A clinical case report

open access: yesClinical Case Reports
Key Clinical Message Tuberculosis (TB) is a rare but known reason for hypercalcemia usually in those with underlying conditions such as renal failure, diabetes, or severe anemia.
Seyed Ali Dehghan Manshadi   +4 more
doaj   +1 more source

Is hypercalcemia a different face of tuberculosis? A case of tuberculosis peritonitis with hypercalcemia

open access: yes, 2016
Hiperkalseminin en sık iki nedeni primer hiperparatiroidizm ve malignite olmasına rağmen granülomatöz hastalıkların seyrinde de hiperkalsemi görülebilir.
Usta, Levent   +4 more
core   +1 more source

Acetate‐ Versus Lactate‐Buffered Crystalloids for Prevention of Post‐ERCP Pancreatitis in Patients Without Access to Rectal NSAIDs: A Multicentre Double‐Blind Randomized Trial

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Background Aggressive peri‐procedural intravenous fluid (IVF) therapy with lactated Ringer's solution (LR) reduces the risk of post‐ERCP pancreatitis (PEP), but the standard 8‐h protocol is impractical in outpatient settings and the optimal fluid type remains uncertain.
Woo Hyun Paik   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy